Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Publication Day
Evidence
Evidence
Hearings Archive
Compensation
Support
Confidential Psychological Support
Interim Payments
Support Groups
Get in touch
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
No decision was taken by Working Party on further study proposal from Dr Brian McClelland.
Published on:
22 July, 2024
Working Party on Transfusion-Associated Hepatitis focused on AIDS – no further discussion of prospective study of NANBH markers.
Published on:
22 July, 2024
Report produced on NANBH in the West of Scotland by Drs Dow and Follett.
Published on:
22 July, 2024
FDA recommended the introduction of both ALT and anti-HBc testing.
Published on:
22 July, 2024
Working Party on Transfusion-Associated Hepatitis reconvened for the first time since 1983 and proposed to discuss a protocol for a multi-centre study.
Published on:
22 July, 2024
SNBTS minutes recorded decision to introduce surrogate testing next year.
Published on:
22 July, 2024
Letter in The Lancet from SNBTS suggested that surrogate testing was "inescapable".
Published on:
22 July, 2024
DHSS granted funding for multi-centre study.
Published on:
22 July, 2024
The Chiron Corporation identified and cloned Hepatitis C virus.
Published on:
22 July, 2024
Dr Craske wrote to Dr Barbara that he did not favour the use of anti-HBc screening.
Published on:
22 July, 2024
At the meeting of the regional transfusion directors, it was noted that the most risky populations might had been identifiable by anti-HBc markers, however no further discussion took place.
Published on:
22 July, 2024
At a meeting of the UK Working Party on Transfusion-Associated Hepatitis, Dr Barbara observed that the anti-HBc test had the value of association with Hepatitis B and NANBH as well as AIDS.
Published on:
22 July, 2024
The CBLA Working Group on AIDS discussed surrogate screening and asked Dr Brian McClelland to submit outline proposals for prospective study.
Published on:
22 July, 2024
The CBLA Working Group on AIDS agreed that a protocol for a study should be drawn up.
Published on:
22 July, 2024
Dr Wallington presented the protocol for a study on surrogate screening at the CBLA Central Committee for Research and Development in Blood Transfusion.
Published on:
22 July, 2024
Application for funding from the MRC was made for the prospective study.
Published on:
22 July, 2024
Direct testing for HTLV-3 was thought to be in the offing.
Published on:
22 July, 2024
Universal screening of blood donations for HIV commenced in the UK.
Published on:
22 July, 2024
Professor Robert Gallo announced that he had identified the virus causing AIDS.
Published on:
22 July, 2024
An internal DHSS minute said that a screening test needed to be introduced "as quickly as possible".
Published on:
22 July, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2062
Page
2063
Page
2064
Page
2065
Current page
2066
Page
2067
Page
2068
Page
2069
Page
2070
…
Next page
Next
Last page
Last